| Electrohydrodynamics: A facile technique to fabricate drug delivery systems S Chakraborty, IC Liao, A Adler, KW Leong Advanced drug delivery reviews 61 (12), 1043-1054, 2009 | 696 | 2009 |
| CRISPR/Cas9-based genome editing for disease modeling and therapy: challenges and opportunities for nonviral delivery HX Wang, M Li, CM Lee, S Chakraborty, HW Kim, G Bao, KW Leong Chemical reviews 117 (15), 9874-9906, 2017 | 566 | 2017 |
| Nonviral gene editing via CRISPR/Cas9 delivery by membrane-disruptive and endosomolytic helical polypeptide HX Wang, Z Song, YH Lao, X Xu, J Gong, D Cheng, S Chakraborty, ... Proceedings of the National Academy of Sciences 115 (19), 4903-4908, 2018 | 290 | 2018 |
| A CRISPR/Cas9-based system for reprogramming cell lineage specification S Chakraborty, HY Ji, AM Kabadi, CA Gersbach, N Christoforou, ... Stem cell reports 3 (6), 940-947, 2014 | 243 | 2014 |
| Electrospraying: a facile technique for synthesis of chitosan‐based micro/nanospheres for drug delivery applications N Arya, S Chakraborty, N Dube, DS Katti Journal of Biomedical Materials Research Part B: Applied Biomaterials: An …, 2009 | 224 | 2009 |
| HPV Oncogene Manipulation Using Nonvirally Delivered CRISPR/Cas9 or Natronobacterium gregoryi Argonaute YH Lao, M Li, MA Gao, D Shao, CW Chi, D Huang, S Chakraborty, TC Ho, ... Advanced Science 5 (7), 1700540, 2018 | 102 | 2018 |
| Induced pluripotent stem cell-derived cardiac progenitors differentiate to cardiomyocytes and form biosynthetic tissues N Christoforou, B Liau, S Chakraborty, M Chellapan, N Bursac, KW Leong PloS one 8 (6), e65963, 2013 | 74 | 2013 |
| Transdifferentiation of human endothelial progenitors into smooth muscle cells HY Ji, L Atchison, Z Chen, S Chakraborty, Y Jung, GA Truskey, ... Biomaterials 85, 180-194, 2016 | 59 | 2016 |
| Core transcription factors, microRNAs, and small molecules drive transdifferentiation of human fibroblasts towards the cardiac cell lineage N Christoforou, S Chakraborty, RD Kirkton, AF Adler, RC Addis, ... Scientific reports 7 (1), 40285, 2017 | 50 | 2017 |
| Biostable electrospun microfibrous scaffolds mitigate hypertrophic scar contraction in an immune-competent murine model ER Lorden, KJ Miller, MM Ibrahim, L Bashirov, E Hammett, S Chakraborty, ... Acta biomaterialia 32, 100-109, 2016 | 40 | 2016 |
| A robust strategy for negative selection of Cre-loxP recombination-based excision of transgenes in induced pluripotent stem cells S Chakraborty, N Christoforou, A Fattahi, RW Herzog, KW Leong PloS one 8 (5), e64342, 2013 | 27 | 2013 |
| Bioreactor model of neuromuscular junction with electrical stimulation for pharmacological potency testing SN Charoensook, DJ Williams, S Chakraborty, KW Leong, ... Integrative Biology 9 (12), 956-967, 2017 | 19 | 2017 |
| Cellular target engagement approaches to monitor epigenetic reader domain interactions AN Phillipou, CS Lay, CE Carver, C Messenger, JP Evans, AJ Lewis, ... SLAS DISCOVERY: Advancing the Science of Drug Discovery 25 (2), 163-175, 2020 | 10 | 2020 |
| Vector modifications to eliminate transposase expression following piggyBac-mediated transgenesis S Chakraborty, HY Ji, J Chen, CA Gersbach, KW Leong Scientific reports 4 (1), 7403, 2014 | 9 | 2014 |
| Differentiation of Human-Induced Pluripotent Stem Cells (iPSCs) on Laminin-functionalized PEG Hydrogels under Nucleus Pulposus-Like Culture Conditions L Jing, AT Francisco, S Chakraborty, KW Leong, LA Setton, J Chen Global Spine Journal 4 (1_suppl), s-0034-1376571-s-0034-1376571, 2014 | 1 | 2014 |
| Abstract A012: Analytical validation of a cfDNA-based fragmentomic profiling assay for the detection and quantification of 14 HPV types in cervical cancer S Kumar, J Hutcheson, D Conway, M Horan, S Chakraborty, C Wiseman, ... Clinical Cancer Research 30 (21_Supplement), A012-A012, 2024 | | 2024 |
| Analytical validation of a cfDNA-based fragmentomic profiling assay for the detection and quantification of 14 HPV types in cervical cancer S Kumar, J Hutcheson, D Conway, M Horan, S Chakraborty, C Wiseman, ... CLINICAL CANCER RESEARCH 30 (21), 2024 | | 2024 |
| CRISPR/Cas9-Based Transcriptional Activation of Endogenous Myod1 to Reprogram Murine Fibroblasts into Skeletal Myocytes S Chakraborty, HY Ji, AM Kabadi, CA Gersbach, N Christoforou, ... MOLECULAR THERAPY 22, S215-S215, 2014 | | 2014 |
